Xiaorong Hou

17PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 08, 2026
From local control to immune synergy: the evolving role of stereotactic body radiotherapy in the immunotherapy era of hepatocellular carcinoma.

|Jun 29, 2026
Exploring the molecular classification-based personalized treatment decision-making in FIGO stage I-III endometrial carcinoma after surgery: a population-based real-world study.

|May 29, 2026
Extended-field intensity-modulated radiation therapy and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic or common iliac lymph nodes: a multicenter prospective cohort study.

|May 15, 2026
Annual hazard rates for early-stage endometrial carcinoma after postoperative radiotherapy under FIGO 2023 staging system: results from a population-based single-center cohort study.

|Jan 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Jing Yang, Qiu-Zi Zhong, Li-Ting Qian

|Aug 29, 2025
Timing of adjuvant radiotherapy for early-stage endometrial carcinoma: a single-center retrospective cohort study.

Zihan Yan, Wenhui Wang, Shuning Jiao

Pageof 3

Frequent Collaborators

5 joint publications

Jiabin Ma

4 joint publications

Fuquan Zhang

4 joint publications

Fuquan Zhang

3 joint publications

Zihan Yan